Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression

Leuk Lymphoma. 2024 Dec;65(12):1901-1904. doi: 10.1080/10428194.2024.2381647. Epub 2024 Aug 1.

Authors

Charalampos Charalampous¹, Kimberley Doucette^{1

2}, Aimee Chappell^{1

2}, David H Vesole^{1

2

3}

Affiliations

¹ Division of Medicine, Georgetown University School of Medicine, Washington, DC, USA.
² Division of Hematology and Oncology, Georgetown University School of Medicine, Washington, DC, USA.
³ Myeloma Division, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA.

PMID: 39088749
DOI: 10.1080/10428194.2024.2381647

No abstract available

Keywords: Venetoclax; plasma cell leukemia; transplant.